Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria
- PMID: 25672293
- PMCID: PMC4604509
- DOI: 10.1007/s10157-015-1090-6
Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria
Abstract
Background: Whether to perform a renal biopsy for isolated hematuria remains a matter of controversy. We performed renal biopsy in hematuria without overt proteinuria patients and reported the proportion of glomerulonephritis, pathological activities, and statistical analysis of indicators associated with glomerulonephritis.
Methods: Among 203 patients who underwent renal biopsy in Okubo Hospital, Japan, between January 2008 and October 2013, we identified 56 patients who fulfilled the criteria: (1) urine dipstick examination shows equal to or greater than ± blood on three or more visits, (2) proteinuria <0.3 g/day (g/g Cr), (3) eGFR ≧60 ml/min/1.73 m(2), and (4) no current medication for renal disease. We investigated biopsy findings and compared the clinical indicators in the IgA nephropathy (IgAN) and non-IgAN group.
Results: The pathological diagnosis was IgAN in 35 cases (62 %), thin basement membrane disease (TBMD) in 7 (13 %), minor glomerular abnormality (MGA) in 6 (11 %), glomerular basement membrane (GBM) abnormality in 5 (9 %), and others in 3 (5 %). The histological grade of IgAN was I in 90 % and II in 10; 31 % of patients had some crescentic lesions. Comparisons between the IgAN and non-IgAN group revealed significant differences in age of onset (26 ± 13 vs. 34 ± 17 years, p = 0.04), serum IgA (340 ± 114 vs. 220 ± 101 mg/dl, p < 0.01), proteinuria (0.08 [0-0.25] vs. 0 [0-0.23] g/day [g/gCr], p < 0.01), and the presence of poikilocytes (40 vs. 10 %, p = 0.02).
Conclusions: The proportion of IgAN in hematuria without overt proteinuria was high and the pathological activities were variable. Patients with hematuria without overt proteinuria should continue their medical follow-up and the best timing of biopsy may be controversial for these patients who have multiple risk factors of IgAN.
Keywords: Hematuria without overt proteinuria; IgA nephropathy; Renal biopsy.
Figures
Similar articles
-
Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.Kidney Blood Press Res. 2015;40(2):200-6. doi: 10.1159/000368495. Epub 2015 Apr 6. Kidney Blood Press Res. 2015. PMID: 25924707
-
The width of the basement membrane does not influence clinical presentation or outcome of thin glomerular basement membrane disease with persistent hematuria.Kidney Int. 2010 Nov;78(10):1041-6. doi: 10.1038/ki.2010.285. Epub 2010 Aug 11. Kidney Int. 2010. PMID: 20703213
-
[Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].Zhonghua Er Ke Za Zhi. 2004 Jun;42(6):412-6. Zhonghua Er Ke Za Zhi. 2004. PMID: 15265422 Chinese.
-
Factors predicting progression of IgA nephropathies.J Nephrol. 2005 Sep-Oct;18(5):503-12. J Nephrol. 2005. PMID: 16299675 Review.
-
The pathological and outcome characteristics of renal lesions in Crohn's disease.BMC Nephrol. 2022 Jul 18;23(1):256. doi: 10.1186/s12882-022-02883-8. BMC Nephrol. 2022. PMID: 35850695 Free PMC article. Review.
Cited by
-
Association between 3-Year Repetitive Isolated Hematuria and eGFR Deterioration in an Apparently Healthy Population: A Retrospective Cohort Study.Int J Environ Res Public Health. 2022 Sep 12;19(18):11466. doi: 10.3390/ijerph191811466. Int J Environ Res Public Health. 2022. PMID: 36141738 Free PMC article.
-
Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy.J Clin Med. 2022 Jun 2;11(11):3173. doi: 10.3390/jcm11113173. J Clin Med. 2022. PMID: 35683557 Free PMC article.
-
Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?Clin Exp Immunol. 2016 Nov;186(2):115-133. doi: 10.1111/cei.12823. Epub 2016 Sep 8. Clin Exp Immunol. 2016. PMID: 27283488 Free PMC article. Review.
-
Fluctuation of R2* values in blood oxygenation level-dependent MRI during acute and remission phases of IgA vasculitis with nephritis in children.Jpn J Radiol. 2022 Aug;40(8):840-846. doi: 10.1007/s11604-022-01267-0. Epub 2022 Mar 31. Jpn J Radiol. 2022. PMID: 35357626
-
A case of latent heterozygous Fabry disease in a female living kidney donor candidate.CEN Case Rep. 2021 Feb;10(1):30-34. doi: 10.1007/s13730-020-00510-9. Epub 2020 Jul 25. CEN Case Rep. 2021. PMID: 32712909 Free PMC article.
References
-
- McGregor DO, Lynn KL, Balley RR, Robson RA, Gardner J. Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria. Clin Nephrol. 1998;49:345–348. - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous